帕金森病模型中星形胶质细胞驱动过量铁转移
Microglia drive excessive iron transfer in Parkinson's disease models
研究发现NUS1基因缺陷可导致星形胶质细胞释放过多铁,损害多巴胺能神经元,揭示了帕金森病的新机制。
Parkinson's disease (PD) is a neurodegenerative condition associated with worsening tremors, slowed movements, changes in walking and speech, muscle rigidity and postural instability. Many of its symptoms are associated with a progressive loss of dopamine-producing neurons in a brain region called the substantia nigra pars compacta.
Neuroscientists have been trying to better understand the processes via which the disease causes damage to these specific neurons. This could in turn help to develop treatments that do not merely help to manage the condition, but that can also slow its progression.
Researchers at Soochow University and other institutions recently investigated the possible involvement of the gene NUS1, certain variants of which are associated with a higher risk of PD, in processes that can lead to PD-related neuronal damage. The results of their study, published in Nature Neuroscience, suggest that a deficiency of the protein encoded by this gene could cause brain immune cells to release too much iron, which was found to damage or kill neurons in mouse models of PD.
Excessive iron transfer damages dopamine-producing neurons
The NUS1 gene encodes instructions for making a protein called neurite outgrowth inhibitor-B receptor (NgBR). This protein helps cells to produce molecules that help to process and modify other proteins.
Recent studies found that some variants of NUS1 are linked to a higher risk of PD. To better understand how the gene may contribute to neuronal damage in PD, the researchers carried out experiments with genetically modified mice that lacked Nus1 in microglia (i.e., the brain's resident immune cells).
The researchers studied the mice's brains, monitoring their movements and the survival of dopamine-producing neurons in their substantia nigra as they aged. They also reduced NgBR expression in laboratory-grown mouse and human microglia to observe the cellular mechanisms that followed. Their analyses specifically focused on changes in gene expression, cellular stress and the release of iron.
The team also examined lipocalin-2 (LCN2), a protein that binds iron-containing molecules and helps to transport iron between cells. They compared the effects of LCN2 carrying iron with LCN2 carrying no iron on neurons, to determine whether the iron cargo could be responsible for neuronal damage.
In addition, they looked at a protein that allows LCN2 to enter brain cells, called SLC22A17. They then tried to understand if blocking this iron-transfer route could protect neurons and reduce PD-like movement changes in mice.
"We show that NgBR is highly expressed in microglia, where its deficiency drives progressive PD-like motor deficits and dopaminergic neurodegeneration via the LCN2–SLC22A17 iron-transport axis in mice," wrote Lele Liu, Yan Hong and their colleagues in their paper.
"NgBR deficiency in mouse and human microglia triggers endoplasmic reticulum stress and PERK–ATF4–NUPR1 signaling, which preferentially induces LCN2-mediated iron efflux over cytokine release. Subsequently, microglia-derived iron-loaded Holo-LCN2, but not iron-free Apo-LCN2, is internalized by SLC22A17, a receptor highly expressed in dopaminergic neurons, leading to iron overload and ferroptosis."
A possible route to interrupt the undesirable process
The researchers were able to identify a mechanism via which loss of NUS1 function could contribute to PD-associated damage to dopamine-producing neurons. Specifically, they found that a lack of NgBR in microglia could cause cellular stress and an excessive release of iron, leading to an overload of iron in neurons and ferroptosis, a form of cell death driven by iron-dependent oxidative damage to cellular lipids.
When they blocked this pathway or inhibited ferroptosis in mice lacking microglial NgBR, fewer dopamine-producing neurons were lost and PD-like movement impairments were reduced. Importantly, the study does not establish that blocking the pathway would also slow down the progression of PD in humans.
In the future, the team's findings could prompt further research with patient-derived brain tissue samples. Additional studies would also need to establish whether the pathway can be safely targeted in humans while preserving the iron balance that supports brain function.
"Pharmacological inhibition of LCN2–SLC22A17 axis or ferroptosis alleviated dopaminergic neuron loss and PD-like symptoms caused by microglial NgBR deficiency in vitro and in vivo," wrote the authors. "Our findings identify disrupted intercellular iron homeostasis as a pathological driver of PD and highlight the LCN2–SLC22A17 axis as a potential therapeutic target."
Written for you by our author Ingrid Fadelli, edited by Gaby Clark, and fact-checked and reviewed by Robert Egan—this article is the result of careful human work. We rely on readers like you to keep independent science journalism alive. If this reporting matters to you, please consider a donation (especially monthly). You'll get an ad-free account as a thank-you.
Publication details
Lele Liu et al., Microglial NUS1 deficiency drives dopaminergic neurodegeneration through intercellular iron dysregulation in Parkinson's disease models, Nature Neuroscience (2026). DOI: 10.1038/s41593-026-02499-3.
Journal information: Nature Neuroscience
Clinical categories
Who's behind this story?
Ingrid Fadelli
Freelance journalist with BSc Psychology and MA International Journalism. Covers AI, robotics, neuroscience, and astrophysics since 2018. Full profile →
Gaby Clark
MA in English, copy editor since 2021 with experience in higher education and health content. Dedicated to trustworthy science news. Full profile →
Robert Egan
Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →
© 2026 Science X Network
Citation: Microglia drive excessive iron transfer in Parkinson's disease models (2026, November 5) retrieved 5 November 2026 from https://medicalxpress.com/news/2026-11-microglia-excessive-iron-parkinson-disease.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Medical Xpress · medicalxpress.com